BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Majewska A, Mlynarczyk-Bonikowska B. 40 Years after the Registration of Acyclovir: Do We Need New Anti-Herpetic Drugs? Int J Mol Sci 2022;23:3431. [PMID: 35408788 DOI: 10.3390/ijms23073431] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Jurak I, Cokarić Brdovčak M, Djaković L, Bertović I, Knežević K, Lončarić M, Jurak Begonja A, Malatesti N. Photodynamic Inhibition of Herpes Simplex Virus 1 Infection by Tricationic Amphiphilic Porphyrin with a Long Alkyl Chain. Pharmaceutics 2023;15:956. [DOI: 10.3390/pharmaceutics15030956] [Reference Citation Analysis]
2 To EE. Cell and Tissue Specific Metabolism of Nucleoside and Nucleotide Drugs: Case Studies and Implications for Precision Medicine. Drug Metab Dispos 2023;51:360-8. [PMID: 36446610 DOI: 10.1124/dmd.122.000856] [Reference Citation Analysis]
3 Abeywickrema M, Kelly D, Kadambari S. Management of neonatal central nervous system viral infections: Knowledge gaps and research priorities. Rev Med Virol 2023;33:e2421. [PMID: 36639694 DOI: 10.1002/rmv.2421] [Reference Citation Analysis]
4 Al-maliki L, Oohayyed NA, Mohameed EE, Suleiman AA, Shaban SA. Identification of Novel Drug Targets and Immune Response Biomarkers in HCMV-Infected Hosts.. [DOI: 10.21203/rs.3.rs-2608712/v1] [Reference Citation Analysis]
5 Bakacs T, Sandig V, Kovesdi I. Combination Therapy for the Treatment of Shingles with an Immunostimulatory Vaccine Virus and Acyclovir. Pharmaceuticals 2023;16:226. [DOI: 10.3390/ph16020226] [Reference Citation Analysis]
6 Huntjens DW, Dijkstra JA, Verwiel LN, Slijkhuis M, Elbers P, Welkers MRA, Veldkamp AI, Kuijvenhoven MA, de Leeuw DC, Abdullah-Koolmees H, Kuipers MT, Bartelink IH. Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients. Pharmaceutics 2023;15. [PMID: 36678792 DOI: 10.3390/pharmaceutics15010163] [Reference Citation Analysis]
7 Kim SH. Current scenario and future applicability of antivirals against herpes zoster. Korean J Pain 2023;36:4-10. [PMID: 36573010 DOI: 10.3344/kjp.22391] [Reference Citation Analysis]
8 Krylova NV, Gorbach VI, Iunikhina OV, Pott AB, Glazunov VP, Kravchenko AO, Shchelkanov MY, Yermak IM. Antiherpetic Activity of Carrageenan Complex with Echinochrome A and Its Liposomal Form. Int J Mol Sci 2022;23. [PMID: 36555404 DOI: 10.3390/ijms232415754] [Reference Citation Analysis]
9 Kotton BD, Kotton CN. Resistant herpes simplex virus infections - who, when, and what's new? Curr Opin Infect Dis 2022;35:530-5. [PMID: 36206151 DOI: 10.1097/QCO.0000000000000889] [Reference Citation Analysis]
10 Karpov DS, Demidova NA, Kulagin KA, Shuvalova AI, Kovalev MA, Simonov RA, Karpov VL, Snezhkina AV, Kudryavtseva AV, Klimova RR, Kushch AA. Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems. Int J Mol Sci 2022;23. [PMID: 36499174 DOI: 10.3390/ijms232314847] [Reference Citation Analysis]
11 Hassan STS, Šudomová M, Mazurakova A, Kubatka P. Insights into Antiviral Properties and Molecular Mechanisms of Non-Flavonoid Polyphenols against Human Herpesviruses. Int J Mol Sci 2022;23. [PMID: 36430369 DOI: 10.3390/ijms232213891] [Reference Citation Analysis]
12 Zannella C, Chianese A, De Bernardo M, Folliero V, Petrillo F, De Filippis A, Boccia G, Franci G, Rosa N, Galdiero M. Ophthalmic Solutions with a Broad Antiviral Action: Evaluation of Their Potential against Ocular Herpetic Infections. Microorganisms 2022;10:1728. [DOI: 10.3390/microorganisms10091728] [Reference Citation Analysis]